Shuttle Pharmaceuticals Holdings, Inc. — Form 8-K
Filed September 11, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed on 2026-09-11 reports Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits) for the period ending 2026-09-09. The filing provides no substantive detail on what was voted, outcomes, or financial impact. No counterparties, dollar amounts, percentages, or share counts are disclosed in this stub filing.
Why this rating
Bare-bones 8-K with no specifics disclosed. Cannot assess shareholder vote impact without voting results or proposals disclosed. Relative to $4.7M market cap, magnitude unknown and unknowable from this filing.
Extracted items
- 5.07 shareholder vote
- 9.01 exhibits
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.